Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SFN | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-06 |
mRNA | CTSV | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | MIA-RAB4B | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
mRNA | PAK6 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
mRNA | C1orf106 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
mRNA | TRIM51 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
mRNA | PSMC3IP | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | PKP3 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-06 |
mRNA | EID2B | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
mRNA | C1orf116 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |